|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Lipase
Test CodeLIP
Preferred Specimen
1 mL serum
Patient Preparation
The assay manufacturer Beckman Coulter advises: "N-Acetyl Cysteine (NAC), when administered in therapeutic concentrations (for the treatment of acetaminophen overdose), has been...determined to interfere with assays for...cholesterol, uric acid" where "NAC interference may lead to falsely low results." According to Beckman Coulter, the NAC interference should be insignificant by 12 hours after completion of the initial loading dose of an IV infusion treatment regimen consisting of an initial loading dose of 150 mg/kg administered over 1 hour, a second dose of 50 mg/kg administered over 4 hours and a third dose of 100 mg/kg administered over 16 hours.
Minimum Volume
0.5 mL
Other Acceptable Specimens
Heparinized plasma
Instructions
Note: N-acetyl-p-benzoquinone imine (NAPQI) (metabolite of acetaminophen) will generate erroneously low results in samples for patients that have taken toxic doses of acetaminophen.
Transport Container
Serum separator tube (SST)
Transport Temperature
Ambeint
Specimen Stability
Refrigerated: 7 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Grossly icteric
Methodology
Spectrophotometry (SP)
Setup Schedule
24/7
Report Available
Same day
Reference Range
16-63 U/L
Clinical Significance
Confirmatory evidence for diagnosis of pancreatitis.